NCT00231868 - A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Uterine Cancer

Interventions

DRUG

Carboplatin and Paclitaxel and Pelvic Radiation Therapy

Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=6.5) Repeat q 21 days x 3 cycles followed by RT followed by Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=5.0)Repeat q 21 days x 3 cycles

PROCEDURE

Carboplatin and Paclitaxel and Pelvic Radiation Therapy

Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=6.5) Repeat q 21 days x 3 cycles followed by RT followed by Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=5.0)Repeat q 21 days x 3 cycles

DRUG

Carboplatin and Paclitaxel and Radiation Therapy

Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=6.5) Repeat q 21 days x 3 cycles followed by RT followed by Paclitaxel 175 mg/m2/3 hour \& Carboplatin (AUC=5.0)Repeat q 21 days x 3 cycles

Trial Locations (1)

10461

Montefiore Medical Center, The Bronx

All Listed Sponsors

lead

Montefiore Medical Center

OTHER